Overview

Cardiovascular Monitoring and Diagnostic Devices Market is poised to value over CAGR of over 7.7% during the forecast period 2022 to 2028.

The cardiovascular monitoring devices are primarily used in identifying pressure and electrical waveforms of the cardiovascular system which in turns assists in measuring and managing chronic cardiovascular disorders. The high-level data acquisition precision offered by these analyzers is one of the significant factors that has assisted in the growth of the cardiovascular monitoring and diagnostic devices market. The growing obese population and unhealthy dietary choices has led to an increase in the number of patients diagnosed with chronic cardiovascular diseases. This has resulted in patients registering for various cardio-related tests in hospitals which has increases the demand for these monitoring and diagnostic devices significantly.       

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cardiovascular Monitoring and Diagnostic Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cardiovascular Monitoring and Diagnostic Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Cardiovascular Monitoring and Diagnostic Devices Market:

• GE Healthcare
• Philips Healthcare
• Spacelabs Healthcare
• St. Jude Medical Inc.
• Siemens Healthcare  
• Boston Scientific Corporation
• Nihon Kohden Corporation
• Welch Allyn Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Cardiovascular Monitoring and Diagnostic Devices Market Segmentation:

By Product

• ECG Systems
• Resting ECG
• Stress ECG
• Event Monitors
• Holter Monitors
• Implantable Loop Recorders
• ECG Management Systems  

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Cardiovascular Monitoring and Diagnostic Devices Market By Product and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 

 2.  Research Methodology 
       2.1 Research Data 
              2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
              2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  

3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights

4. Global Cardiovascular Monitoring and Diagnostic Devices Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview
       5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Cardiovascular Monitoring and Diagnostic Devices Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Cardiovascular Monitoring and Diagnostic Devices Market Analysis Tools
       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies

7. Global Cardiovascular Monitoring and Diagnostic Devices Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
       7.1. ECG Systems
            7.1.1. Resting ECG
            7.1.2. Stress ECG
       7.2. Event Monitors
       7.3. Holter Monitors
       7.4. Implantable Loop Recorders
       7.5. ECG Management Systems  

8.  North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       8.1. Introduction
       8.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            8.2.1. U.S.A
            8.2.2. Canada
            8.2.3. Mexico
       8.3. Market Size (USD Million) Forecast for North America 2022-2028

9. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       9.1. Introduction
       9.2. Regional Market Trends
       9.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            9.3.1. Brazil
            9.3.2. Venezuela
            9.3.3. Argentina
            9.3.4. Rest of Latin America
       9.4. Market Size (USD Million) Forecast for Latin America 2022-2028

10. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       10.1. Introduction
       10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            10.2.1. Germany
            10.2.2. U.K
            10.2.3. France
            10.2.4. Italy
            10.2.5. Spain
            10.2.6. Russia
            10.2.7. Poland
            10.2.8. Switzerland
            10.2.9. Rest of Western Europe

11. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       11.1. Introduction
       11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             11.2.1. Japan
             11.2.2. China
             11.2.3. Singapore
             11.2.4. India
             11.2.5. Australia and New Zealand
             11.2.6. ASEAN
             11.2.7. South Korea
             11.2.8. Rest of Asia Pacific
       11.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028

12. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       12.1. Introduction
       12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             12.2.1. GCC
             12.2.2. Israel
             12.2.3. South Africa
             12.2.4. Rest of MEA
       12.3. Market Size (USD Million) Forecast for MEA 2022-2028

13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
       13.1. GE Healthcare
                13.1.1. Company Overview
                13.1.2. Product Portfolio
                13.1.3. SWOT Analysis
                13.1.4. Financial Overview
                13.1.5. Strategic Overview
       13.2. Philips Healthcare
                13.2.1. Company Overview
                13.2.2. Product Portfolio
                13.2.3. SWOT Analysis
                13.2.4. Financial Overview
                13.2.5. Strategic Overview
       13.3. Spacelabs Healthcare
                13.3.1. Company Overview
                13.3.2. Product Portfolio
                13.3.3. SWOT Analysis
                13.3.4. Financial Overview
                13.3.5. Strategic Overview
       13.4. St. Jude Medical Inc.
                13.4.1. Company Overview
                13.4.2. Product Portfolio
                13.4.3. SWOT Analysis
                13.4.4. Financial Overview
                13.4.5. Strategic Overview
       13.5. Siemens Healthcare
                13.5.1. Company Overview
                13.5.2. Product Portfolio
                13.5.3. SWOT Analysis
                13.5.4. Financial Overview
                13.5.5. Strategic Overview
       13.6. Boston Scientific Corporation
                13.6.1. Company Overview
                13.6.2. Product Portfolio
                13.6.3. SWOT Analysis
                13.6.4. Financial Overview
                13.6.5. Strategic Overview
       13.7. Nihon Kohden Corporation
                13.7.1. Company Overview
                13.7.2. Product Portfolio
                13.7.3. SWOT Analysis
                13.7.4. Financial Overview
                13.7.5. Strategic Overview
       13.8. Welch Allyn Inc.
                13.8.1. Company Overview
                13.8.2. Product Portfolio
                13.8.3. SWOT Analysis
                13.8.4. Financial Overview
                13.8.5. Strategic Overview
14. Pre and Post COVID-19 Impact
    14.1. Positive influence on the healthcare industry
    14.2. The financial disruption of the manufacturing sector
    14.3. Impact of COVID-19 on emerging companies
    14.4. Significant mandates in the healthcare regulations initiated by administrations
    14.5. The overall economic slowdown of the developing and developed nations
15. FutureWise SME key takeaway points for Client

Tables

Figures